United Therapeutics Corporation (UTHR) Total liabilities 2016–2025
United Therapeutics Corporation (UTHR) total liabilities at each fiscal year-end, per SEC filings.
$783.8MFY2025 · since FY2016: $463.4M → $783.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $783.8M | -14.8% |
| FY2024 | $920.0M | -22.2% |
| FY2023 | $1.2B | -5.3% |
| FY2022 | $1.2B | +3.1% |
| FY2021 | $1.2B | -0.8% |
| FY2020 | $1.2B | +7.7% |
| FY2019 | $1.1B | +91.0% |
| FY2018 | $593.2M | -21.8% |
| FY2017 | $758.4M | +63.7% |
| FY2016 | $463.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More UTHR financial trends
UTHR RevenueUTHR Net incomeUTHR Net marginUTHR Gross profitUTHR Gross marginUTHR Operating incomeUTHR Operating marginUTHR Operating cash flowUTHR Free cash flowUTHR Capital expendituresUTHR Return on equityUTHR Stock buybacksUTHR Dividends paidUTHR Total assetsUTHR Shareholders’ equityUTHR overview →